Business Context and Reporting Period
Company: Graham Corporation (NYSE: GHM)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and nine months ended December 31, 2024 (Fiscal Year 2025)
Business Overview: A global leader in mission-critical fluid, power, heat transfer, and vacuum technologies serving defense, space, energy, and process industries. The company operates through its Batavia, NY headquarters and subsidiaries including Barber-Nichols (BN) and the recently acquired P3 Technologies.
Key Financial Metrics
| Metric ($ in thousands) | 3 Months Ended Dec 31, 2024 |
3 Months Ended Dec 31, 2023 |
9 Months Ended Dec 31, 2024 |
9 Months Ended Dec 31, 2023 |
|---|---|---|---|---|
| Net Sales | $47,037 | $43,818 | $150,551 | $136,463 |
| Gross Profit | $11,686 | $9,723 | $36,853 | $27,891 |
| Gross Margin | 24.8% | 22.2% | 24.5% | 20.4% |
| Operating Income | $2,210 | $911 | $9,669 | $5,398 |
| Net Income | $1,588 | $165 | $7,835 | $3,216 |
| Diluted EPS | $0.14 | $0.02 | $0.71 | $0.30 |
| Cash & Equivalents | $30,046 | $16,939 (Mar 31, 2024) | N/A | |
| Operating Cash Flow (9mo) | N/A | $27,873 | $19,483 | |
| Capital Expenditures (9mo) | N/A | ($13,800) | ($5,193) | |
| Backlog | $384,701 | $399,244 (Dec 31, 2023) | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7% in Q3 and 10% for the nine-month period. Growth was driven by an 11% increase in Defense sales (new programs, better execution) and a 64% surge in Chemical/Petrochemical sales. This was partially offset by a 16% decline in Refining revenue due to project timing in India.
- Margin Expansion: Gross margin improved by 260 basis points in Q3 (24.8% vs 22.2%) due to fixed cost leverage, improved pricing, and a $255k benefit from a BlueForge Alliance grant for defense welder training.
- Profitability: Net income surged to $1.6M in Q3 from $165k in the prior year, primarily due to higher sales volume, margin expansion, and a $946k gain from the change in fair value of the P3 contingent earn-out liability.
- Orders: Q3 orders dropped significantly to $24.8M from a record $123.3M in the prior year, attributed to the timing of large U.S. Navy programs (Columbia Class submarine and Ford Class carrier).
- Acquisition Impact: The P3 Technologies acquisition contributed $963k in sales and $184k in net income for the nine months ended Dec 31, 2024.
Guidance, Outlook, and Risks
Updated Fiscal 2025 Guidance
- Net Sales: $200M - $210M (Unchanged)
- Gross Profit Margin: 24% - 25% (Raised from 23% - 24%)
- SG&A Expenses: 18% - 19% of sales (Raised from 17% - 18%)
- Effective Tax Rate: 20% - 22% (Unchanged)
- Adjusted EBITDA: $18M - $21M (Unchanged)
- Capital Expenditures: $15M - $19M (Raised from $13M - $18M due to land purchase in Colorado and cryogenic testing facility in Florida)
Management Commentary & Risks
- Leadership Transition: CEO Daniel J. Thoren will transition to Executive Chairman in June 2025; Matthew J. Malone will become President/COO and is expected to assume the CEO role in June 2025.
- Legal Contingencies: The company is defending against asbestos-related lawsuits, which management believes will not have a material adverse effect. Additionally, an investigation into misconduct at the Graham India subsidiary (GIPL) totaling $150k over four years was concluded; involved employees were terminated, and authorities were notified.
- Market Risks: Exposure to foreign currency fluctuations (16% of sales international), geopolitical tensions affecting supply chains, and the lumpy nature of defense and space orders.
Investor Verification Checklist
- Backlog Conversion: Verify the timing of revenue recognition for the $384.7M backlog, noting that 80% is Defense-related with long conversion cycles (up to 6 years).
- Capital Expenditure Utilization: Monitor the execution of the increased CapEx guidance ($15M-$19M), specifically the new cryogenic testing facility and land acquisition.
- Defense Program Stability: Assess the impact of the significant drop in Q3 orders on future revenue visibility, given the reliance on U.S. Navy programs.
- India Subsidiary Compliance: Review ongoing regulatory cooperation regarding the GIPL whistleblower investigation and its potential impact on operations in the Middle East/India region.
- Non-GAAP Reconciliation: Review the reconciliation of Adjusted Net Income, noting the exclusion of the BN Performance Bonus starting in Q4 FY2024.